JP2015528466A5 - - Google Patents

Download PDF

Info

Publication number
JP2015528466A5
JP2015528466A5 JP2015530070A JP2015530070A JP2015528466A5 JP 2015528466 A5 JP2015528466 A5 JP 2015528466A5 JP 2015530070 A JP2015530070 A JP 2015530070A JP 2015530070 A JP2015530070 A JP 2015530070A JP 2015528466 A5 JP2015528466 A5 JP 2015528466A5
Authority
JP
Japan
Prior art keywords
urea
bar
inclusion body
high pressure
inclusion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015530070A
Other languages
English (en)
Japanese (ja)
Other versions
JP6405308B2 (ja
JP2015528466A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/057430 external-priority patent/WO2014036349A1/en
Publication of JP2015528466A publication Critical patent/JP2015528466A/ja
Publication of JP2015528466A5 publication Critical patent/JP2015528466A5/ja
Application granted granted Critical
Publication of JP6405308B2 publication Critical patent/JP6405308B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015530070A 2012-08-30 2013-08-30 キメラksacタンパク質の発現及び高圧により可溶性タンパク質を製造する方法 Expired - Fee Related JP6405308B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261694968P 2012-08-30 2012-08-30
US61/694,968 2012-08-30
US201361830425P 2013-06-03 2013-06-03
US61/830,425 2013-06-03
PCT/US2013/057430 WO2014036349A1 (en) 2012-08-30 2013-08-30 Expression of chimeric ksac protein and method of producing soluble proteins by high pressure

Publications (3)

Publication Number Publication Date
JP2015528466A JP2015528466A (ja) 2015-09-28
JP2015528466A5 true JP2015528466A5 (enExample) 2016-08-12
JP6405308B2 JP6405308B2 (ja) 2018-10-17

Family

ID=49162270

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2015530070A Expired - Fee Related JP6405308B2 (ja) 2012-08-30 2013-08-30 キメラksacタンパク質の発現及び高圧により可溶性タンパク質を製造する方法
JP2015530066A Active JP6438396B2 (ja) 2012-08-30 2013-08-30 不活化ワクチンを作製するための、ならびに組換えタンパク質をリフォールディング/可溶化させるための高圧デバイスおよび方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2015530066A Active JP6438396B2 (ja) 2012-08-30 2013-08-30 不活化ワクチンを作製するための、ならびに組換えタンパク質をリフォールディング/可溶化させるための高圧デバイスおよび方法

Country Status (18)

Country Link
US (3) US9169302B2 (enExample)
EP (2) EP2890392B1 (enExample)
JP (2) JP6405308B2 (enExample)
KR (1) KR102208844B1 (enExample)
CN (3) CN104717976A (enExample)
AP (1) AP2015008331A0 (enExample)
AU (4) AU2013308623B2 (enExample)
BR (1) BR112015004463B8 (enExample)
CA (2) CA2883303A1 (enExample)
EA (1) EA031988B1 (enExample)
ES (1) ES2744709T3 (enExample)
HK (1) HK1211874A1 (enExample)
MD (1) MD4608C1 (enExample)
MX (3) MX358782B (enExample)
NZ (3) NZ715459A (enExample)
PH (1) PH12015500700B1 (enExample)
RU (1) RU2647568C2 (enExample)
WO (2) WO2014036349A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8968749B2 (en) * 2006-07-21 2015-03-03 Universidade Federal De Minas Gerais—Ufmg Vaccine composition and immunization method
ZA201501696B (en) 2012-08-30 2016-01-27 Merial Ltd Hyperbaric device and methods for producing inactivated vaccines and for refolding/solubilizing recombinant proteins
MX358782B (es) 2012-08-30 2018-09-04 Merial Inc Expresión de proteina ksac quimérica y método para producir proteínas solubles mediante alta presión.
EP2978447B1 (en) * 2013-03-28 2019-05-08 Infectious Disease Research Institute Vaccines comprising leishmania polypeptides for the treatment and diagnosis of leishmaniasis
CN104758944B (zh) 2015-04-02 2017-11-28 中国科学院过程工程研究所 一种疫苗制剂及其制备方法和用途
JP2018082987A (ja) * 2016-11-25 2018-05-31 株式会社日立製作所 ウイルス不活化方法及びウイルス不活化装置
JP2020152644A (ja) * 2019-03-18 2020-09-24 国立大学法人愛媛大学 Vnarのリフォールディング方法およびvnarの製造方法
US10973908B1 (en) 2020-05-14 2021-04-13 David Gordon Bermudes Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine
CN112120012B (zh) * 2020-09-30 2022-03-22 广东康盾创新产业集团股份公司 一种car-t细胞冻存方法
BR102021000794A2 (pt) * 2021-01-15 2022-07-26 Fundação Oswaldo Cruz Proteína quimérica, kit, método para diagnóstico de leishmaniose, uso de uma proteína quimérica, composição vacinal contra leishmaniose visceral, e, uso de uma composição vacinal

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60500673A (ja) 1983-03-08 1985-05-09 コモンウエルス セラム ラボラトリ−ズ コミツシヨン 抗原活性を有するアミノ酸配列
JP2743177B2 (ja) * 1987-04-24 1998-04-22 財団法人阪大微生物病研究会 百日咳菌の培養方法、及び百日咳トキソイドとその混合ワクチン
US6610661B1 (en) 1996-10-11 2003-08-26 The Regents Of The University Of California Immunostimulatory polynucleotide/immunomodulatory molecule conjugates
US5980912A (en) 1997-03-25 1999-11-09 Zonagen, Inc. Chitosan induced immunopotentiation
FR2771011B1 (fr) 1997-11-17 2000-01-28 Hippocampe Obtention de vaccins destines a prevenir les effets pathogenes associes a une infection retrovirale
FR2775601B1 (fr) 1998-03-03 2001-09-21 Merial Sas Vaccins vivants recombines et adjuves
FR2776928B1 (fr) 1998-04-03 2000-06-23 Merial Sas Vaccins adn adjuves
AU4975699A (en) 1998-07-09 2000-02-01 University Technology Corporation High pressure refolding of protein aggregates and inclusion bodies
EP1180945A1 (en) 1999-05-28 2002-02-27 Universite Laval Inactivation of food spoilage and pathogenic microorganisms by dynamic high pressure
US6645740B1 (en) 1999-06-10 2003-11-11 Merial Limited Nucleic acids encodings equine GM-CSF
AU780979B2 (en) 1999-09-25 2005-04-28 Coley Pharmaceutical Gmbh Immunostimulatory nucleic acids
US7615617B2 (en) 1999-10-25 2009-11-10 University Of Delaware Use of hydrostatic pressure to inhibit and reverse protein aggregation and facilitate protein refolding
AU2002246493A1 (en) 2000-08-10 2002-07-30 Boston Biomedica, Inc. Pressure cycling inactivation of pathogens in biological materials used for therapeutics or vaccines
US6635223B2 (en) 2000-10-25 2003-10-21 Andreas Maerz Method for inactivating micro-organisms using high pressure processing
DE60133426T2 (de) * 2000-10-31 2008-11-13 BaroFold, Inc., Boulder Verbesserter zerfall und rückfaltung von proteinen mittels hohen drucks
AU2003245416A1 (en) 2002-06-07 2004-04-30 University Of Florida Endodontic files made using bulk metallic glasses
SE525457C2 (sv) * 2002-06-24 2005-02-22 Flow Holdings Sagl Förfarande för åstadkommande av en tryckändring mellan två trycktillstånd, högtryckspressanordning samt användning av förfarande eller högtryckspressanordning
WO2005044301A2 (en) * 2003-11-05 2005-05-19 C.B.F. Leti, S.L. Unipersonal Use of specific histones for the treatment of parasitic diseases
US7993580B2 (en) 2004-08-24 2011-08-09 Baxter International Inc. Methods for the inactivation of microorganisms in biological fluids, flow through reactors and methods of controlling the light sum dose to effectively inactivate microorganisms in batch reactors
AU2006318435A1 (en) 2005-11-21 2007-05-31 Barofold, Inc. Devices and methods for high-pressure refolding of proteins
CN200945252Y (zh) * 2006-09-01 2007-09-12 天津市华泰森淼生物工程技术有限公司 手动开启式小型超高压生物处理设备
US20080161242A1 (en) 2006-09-15 2008-07-03 Randolph Theodore W High pressure treatment of proteins for reduced immunogenicity
US7829681B2 (en) 2007-04-05 2010-11-09 Barofold Inc. High-pressure inclusion body solubilization and protease clipping of recombinant fusion proteins
WO2008124134A2 (en) 2007-04-05 2008-10-16 Barofold, Inc. High-pressure refolding of proteins in the presence of binding partners
WO2009045553A1 (en) 2007-10-05 2009-04-09 Barofold, Inc. High pressure treatment of aggregated interferons
AU2008348022B2 (en) * 2007-12-21 2015-03-05 Zoetis Services Llc Heat treated bacterins, and emulsion vaccines prepared from such heat treated bacterins
BRPI0800357A2 (pt) 2008-03-10 2009-10-27 Fundacao Oswaldo Cruz método para produção de uma vacina estabilizada
EP2283035B1 (en) 2008-05-08 2015-07-29 Merial Limited Leishmania vaccine using sand fly salivary immunogen
US8410258B2 (en) * 2008-05-21 2013-04-02 Infections Disease Research Institute Recombinant polyprotein vaccines for the treatment and diagnosis of leishmaniasis
EP2300051B1 (en) 2008-05-21 2014-11-12 Infectious Disease Research Institute Recombinant polyprotein vaccines for the treatment and diagnosis of leishmaniasis
WO2009155102A2 (en) 2008-05-30 2009-12-23 Barofold, Inc. Method for derivatization of proteins using hydrostatic pressure
US20110070219A1 (en) 2009-04-27 2011-03-24 Seefeldt Matthew B High pressure protein crystallization
CA2787320A1 (en) 2010-02-01 2011-08-04 Avure Technologies Ab High-pressure arrangement with locking element preventing rotation of load basket
CN201781934U (zh) * 2010-04-14 2011-04-06 中国农业大学 一种小型框架自动式超高压设备
EP2600843B9 (en) 2010-07-19 2020-03-11 Pressure BioSciences, Inc. Therapeutic protein compositions having reduced immunogenicity and/or improved efficacy
MX358782B (es) * 2012-08-30 2018-09-04 Merial Inc Expresión de proteina ksac quimérica y método para producir proteínas solubles mediante alta presión.
ZA201501696B (en) * 2012-08-30 2016-01-27 Merial Ltd Hyperbaric device and methods for producing inactivated vaccines and for refolding/solubilizing recombinant proteins

Similar Documents

Publication Publication Date Title
JP2015528466A5 (enExample)
WO2019126634A3 (en) Targeted integration of nucleic acids
WO2016196315A3 (en) Cell culture methods and systems
PH12015502441B1 (en) Anti-il-4/anti-il-13 bispecific antibody formulations
NZ704092A (en) Ph adjusted pulse protein product
MY156760A (en) Process for manufacturing succinic acid
MY174160A (en) Polyvinylidene fluoride resin particles and method for producing same
AU2018337668A1 (en) Improved supraparticles
MX2016000314A (es) Tratamiento de suspension liquida de gluten para reducir o remover aflatoxina.
WO2014162308A3 (en) A method of preparing pure precious metal nanoparticles with large fraction of (100) facets, nanoparticles obtained by this method and their use
NZ706288A (en) Expression of chimeric ksac protein and method of producing soluble proteins by high pressure
EP2862627A3 (en) Activated EU-2 zeolite and use thereof in hydroisomerization processes
WO2017025897A3 (en) Capped and uncapped antibody cysteines, and their use in antibody-drug conjugation
MX2019000031A (es) Procedimientos para la preparación de una solución de levotiroxina.
WO2017103600A8 (en) Preparation of respirable zafirlukast particles
WO2016142219A8 (de) Leuchtstoffpartikel mit einer schutzschicht und verfahren zur herstellung der leuchtstoffpartikel mit der schutzschicht
MY187256A (en) Processes for producing acetic acid from a reaction medium having low ethyl iodide content
Moreno et al. Crystallization in gels
MX2025002821A (es) Sistemas y metodos para reducir la formacion de impurezas durante la deshidrocloracion de 244bb a 1234yf
RU2012140308A (ru) Стабильный водный раствор акриламида
CO2018006654A2 (es) Proceso de producción de una gonadotrofina coriónica equina recombinante (recg), composición veterinaria y uso
Hsu et al. Surface modification of commercially pure Ti treated with aqueous NaOH treatment and ethyl alcohol aging
MY194572A (en) Self-sufficient process for the production of biomass hydrolysate with reduced salt content
CN104790010A (zh) 一种微弧氧化电解液新型节能混合添加剂及其应用
MX2015017641A (es) Proceso para la regeneracion de un catalizador de metal noble soportado.